Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-17

Clinical Trial Update: Vytorin in the Treatment of Alopecia Areata [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of Vytorin (ezetimibe/simvastatin) for alopecia areata has completed, per the registry update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: University of Miami | Conditions: Alopecia Areata | Phase 1 | Status: COMPLETED